NCT03766152

Brief Summary

Patients implanted with a Bonebridge will be asked to be part of the study. The study subjects are enrolled into the study according to inclusion criteria. Patients will be asked to wear an adhesive bone conduction device an adapt to it for 30-60 min. After this time period patients will be asked to use the adhesive device instead of the Bonebridge for 3 weeks. Audiologic Tests and quality of life questionnaires will be assessed at the beginning of the study and at the end of three weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2018

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

November 16, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 6, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2019

Completed
Last Updated

January 2, 2020

Status Verified

December 1, 2019

Enrollment Period

12 months

First QC Date

November 16, 2018

Last Update Submit

December 28, 2019

Conditions

Keywords

Hearing aid

Outcome Measures

Primary Outcomes (1)

  • Average functional hearing gain

    The primary endpoint of the study is the average functional hearing gain evaluated by the free field audiometry (at 4 different frequencies) using the bone conduction device compared to the unaided situation. To compare the two hearing devices the following primary endpoint measure will be calculated: Δmean= {(Average functional hearing gain with Bonebridge - Average functional hearing gain with ADHEAR at timepoint T1 (=Δ1)) + (Average functional hearing gain with Bonebridge - Average functional hearing gain with ADHEAR at timepoint T2 (=Δ2))} divided by two. Measuring both hearing devices at both timepoints and using the mean difference (Δmean) enables adjustment for a possible underlying customization effect.

    3 weeks

Secondary Outcomes (4)

  • AQoL-8D (quality of life)

    3 weeks

  • Quality of hearing

    3 weeks

  • Word recognition score

    3 weeks

  • Sentence test

    3 weeks

Study Arms (1)

Adhear

OTHER

Patients will be fitted with an adhesive bone conduction device for three weeks

Device: Adhesive bone conduction hearing aid (ADHEAR - Med El)

Interventions

Patients are asked to wear an adhesive bone conduction hearing device which is attached to the mastoid with an adhesive adapter

Adhear

Eligibility Criteria

Age13 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients implanted with a Bonebridge device and are active users
  • Unilateral and/or bilateral conductive hearing loss (CHL)
  • Subjects aged 13 years or older
  • Capable of the German language
  • Willingness and ability to perform all tests required for the study
  • Signed, and dated informed consent before the start of any study specific procedure

You may not qualify if:

  • Pregnancy or breastfeeding
  • Patient is intolerant of the materials as described by Manufacturer's IFU
  • Patient presents with a skin or scalp condition that may preclude the attachment of the adhesive adapter.
  • Patient cannot perform the audiological tests or is unable to fill out the questionnaires.
  • Patient presents with retrocochlear, or central auditory disorder.
  • any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MUW, AKH

Vienna, 1090, Austria

Location

MeSH Terms

Conditions

Hearing Loss, Conductive

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assoc. Prof PD Dr.

Study Record Dates

First Submitted

November 16, 2018

First Posted

December 6, 2018

Study Start

November 1, 2018

Primary Completion

October 31, 2019

Study Completion

December 13, 2019

Last Updated

January 2, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations